NCT01482091View on ClinicalTrials.gov

Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis

PHASE4CompletedINTERVENTIONAL

Enrollment

124

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

February 28, 2015

Conditions

Anemia, Sickle CellPain

Interventions

DRUG

Fentanyl Citrate

A single dose of fentanyl citrate (2 mcg/kg; max 100mcg) administered intranasally. Half of the volume will be administered in each nare. The medication will be administered using a mucosal atomization device

DRUG

Normal Saline

A single dose of equivalent volume of 0.9% Normal Saline will be administered intranasally. Half of the volume will be administered in each nare. The medication will be administered using a mucosal atomization device.

Trial Locations (1)

10467

Children's Hospital at Montefiore, The Bronx

All Listed Sponsors

lead

Montefiore Medical Center

OTHER

NCT01482091 - Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis | Biotech Hunter | Biotech Hunter